This course will focus on current validation requirements for the manufacture of sterile products and the key areas of importance and audit focus. The instructor will suggest several industry best practices and review a checklist of process and procedures to ensure compliance to current requirements.
Why Should You Attend:
This webinar will highlight and summarize the following main components relating to current validation requirements for sterile products:
It will provide a template of things to ensure in accordance with the stipulated guidance and regulations to help assure sterility and stay compliant.
The regulatory requirements for sterile products are found in a ‘Guidance for Industry’ document that was published in 2004. In addition, there are requirements found in 21 CFR 210-211 and 820. In all of these documents, the areas of importance and audit focus are:
This course will review these key areas of importance that apply to sterile products in order to help attendees evaluate their own processes and procedures. Recent 483 observations will also be reviewed to help highlight common industry deficiencies and as a reference to compare attendees current practices.
Areas Covered in the Webinar:
Who Will Benefit:
This webinar will provide valuable assistance to all personnel in:
Kenneth Christie has over 30 years of sterile manufacturing and regulatory GMP consulting experience in the areas of quality assurance and validation management in the pharmaceutical and biotechnology industries. Mr. Christie is currently the chief operating officer for VTS Consultants, Inc., located in Amherst, MA. His responsibilities specifically include quality system auditing, GMP training, and serving as a subject matter expert for aseptic manufacturing processes, medical devices, APIs and solid dosage processing equipment, utilities, and systems on a global basis. He also performs vendor audits, site pre-approval inspections and assists clients with addressing and correcting regulatory observations.
Mr. Christie was the validation manager at Parke-Davis' Sterile Products Facility where he was involved in the review and approval of all facilities, equipment, and system commissioning/qualification activities. He had routine interaction with the FDA and European inspectors (EMEA), corporate management and third party contract-manufacturing representatives to defend validation practices and to assure regulatory compliance for the manufacture of aseptically produced products.
Mr. Christie is a speaker and trainer for several professional organizations in the US, Canada, Europe, and Asia and is a published author of several articles dealing with the challenges of aseptic processing. Additionally, he serves as a member of the ISPE’s Professional Certification (PCC) Commission as an Examination Development Committee (EDC) member.
Mr. Christie has a BS degree in biology from Shippensburg State University (PA) and an executive MBA degree from Michigan State.
The manufacture of sterile products and the risk they represent to the public is always on the fore front of inspectors during regulatory audits. As a result, the manufacture of sterile products requires a high degree of control of incoming materials, the manufacturing process, and the control of personnel to name a few. A weakness in any of these items can jeopardize the sterility assurance of the final product.
The manufacture of sterile products, whether by aseptic means or terminal sterilization, requires a thorough understanding of applicable regulations by the FDA and those by the EU if selling your products overseas. In addition, there are various guidance documents that address other issues such as closure integrity and sterility test methods that were recently revised in 2012.
Use coupon code NB5SQH8N and get 10% off on registration.